House dust mite allergy immunotherapy sublingual
N/A
Report date: 2022/07/30 20:00:28
Base Information
Drug NameHouse dust mite allergy immunotherapy sublingual
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesHal Allergy
China Registration ClassN/A
Develop Information
Active CompaniesHal Allergy
Inactive CompaniesAlk-Abello SaDanish Alkai--Abeyo Company Beijing Representative OfficeAlk-Abelló A/S +[4]
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A